pharma · ENVB
Enveric Biosciences
Enveric Biosciences patent portfolio — 22 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- CAMBRIDGE, MA, USA
- Programs
- 0
- Drugs
- 0
- Patents
- 22
Enveric Biosciences patents
22 pharmaceutical patents indexed for Enveric Biosciences. 0 expire within 24 months.
Enveric Biosciences has 22 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12428408
Fused heterocyclic mescaline derivatives
granted -
US 12378195
Aminated psilocybin derivatives and methods of using
granted -
US 12358885
Substituted n-propylamine fused heterocyclic mescaline derivatives
granted -
US 12338231
N-heterocycle substituted tryptamine derivatives and methods of using
granted -
US 12195439
C1-substituted isopropylamine fused heterocyclic mescaline derivatives
granted -
US 12187679
Hydroxylated psilocybin derivatives and methods of using
granted -
US 12138276
Halogenated psilocybin derivatives and methods of using
granted -
US 12133856
Multi-substituent psilocybin derivatives and methods of using
granted -
US 12128058
Multi-substituent psilocybin derivatives and methods of using
granted -
US 12077498
C4-carboxylic acid-substituted tryptamine derivatives and methods of using
granted -
US 12065404
C4-carboxylic acid-substituted tryptamine derivatives and methods of using
granted -
US 11998557
Halogenated psilocybin derivatives and methods of using
granted -
US 11945778
C4-carbonothioate-substituted tryptamine derivatives and methods of using
granted -
US 11931338
Nitrilated psilocybin derivatives and methods of using
granted -
US 11918594
Multi-substituent psilocybin derivatives and methods of using
granted -
US 11891360
Glycosylated psilocybin derivatives and methods of using
granted -
US 11858895
Aminated psilocybin derivatives and methods of using
granted -
US 11845726
C4-carbonothioate-substituted tryptamine derivatives and methods of using
granted -
US 11845727
Aldehyde and ketone derivatives of psilocybin and methods of using
granted -
US 11752130
Carboxylated psilocybin derivatives and methods of using
granted -
US 11746087
C4-carboxylic acid-substituted tryptamine derivatives and methods of using
granted -
US 11707447
C4-carbonothioate-substituted tryptamine derivatives and methods of using
granted
Frequently asked questions
How many patents does Enveric Biosciences have?
22 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Enveric Biosciences patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.